Patents Assigned to EFRANAT LTD.
  • MACROPHAGE ACTIVATING FACTOR FOR TREATING BENIGN OR PRECANCEROUS PAPILLOMAS
    Publication number: 20180078613
    Abstract: Provided are pharmaceutical compositions including macrophage activating factor derived from Gc protein (GcMAF) for use in treating benign or precancerous papillomas. Further provided are pharmaceutical compositions including GcMAF for use in treating recurrent respiratory papillomatosis (RRP).
    Type: Application
    Filed: April 6, 2016
    Publication date: March 22, 2018
    Applicant: EFRANAT LTD.
    Inventors: Michal SHAHAR, Uri YOGEV, Rinat ROTEM-YEHUDAR